Mark J. Hamblin
Impact in
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Inhalation and Respiratory Drug Delivery
- Physiology top 10%
- Sarcoidosis and Beryllium Toxicity Research
Papers in
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 6
-
- Photosynthetic Processes and Mechanisms 2
- Porphyrin Metabolism and Disorders 2
- Enzyme Catalysis and Immobilization 1
- Co-authors
- David J. Kelly (4 shared papers)Maureen R. Horton (4 shared papers)Jonathan G. Shaw (3 shared papers)Marlies Wijsenbeek (4 shared papers)Michael Kreuter (4 shared papers)Keith C. Meyer (4 shared papers)Lawrence Ho (4 shared papers)Danielle Antin‐Ozerkis (4 shared papers)
- Journals
- Molecular Microbiology (2 papers)Neurology (1 paper)The Lancet Respiratory Medicine (1 paper)Pulmonary Medicine (1 paper)Journal of Inflammation (1 paper)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
Mark J. Hamblin
17 papers receiving 622 citations
Peers
Comparison fields: 5 of 71
- Pulmonary and Respiratory Medicine 296
- Physiology 180
- Rheumatology 54
- Immunology 60
- Biochemistry 20
Countries citing papers authored by Mark J. Hamblin
This map shows the geographic impact of Mark J. Hamblin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Hamblin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Hamblin more than expected).
Fields of papers citing papers by Mark J. Hamblin
This network shows the impact of papers produced by Mark J. Hamblin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Hamblin. The network helps show where Mark J. Hamblin may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark J. Hamblin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 177 | |
| 2 | 2017 | 129 | |
| 3 | 2019 | 74 | |
| 4 | 2013 | 51 | |
| 5 | 2011 | 49 | |
| 6 | 1991 | 49 | |
| 7 | 1993 | 35 | |
| 8 | 2022 | 25 | |
| 9 | 1990 | 17 | |
| 10 | 2014 | 8 | |
| 11 | Lovastatin Inhibits Low Molecular Weight Hyaluronan Induced Chemokine Expression via LFA-1 and Decreases Bleomycin-Induced Pulmonary Fibrosis. | 2014 | 8 |
| 12 | 2023 | 3 | |
| 13 | 1989 | 3 | |
| 14 | 2025 | 2 | |
| 15 | 2020 | 2 | |
| 16 | 2025 | 1 | |
| 17 | 2019 | 1 |
About Mark J. Hamblin
Mark J. Hamblin is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Epidemiology, Cell Biology and Physiology, having authored 17 papers that have together received 634 indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), Biomarkers in Disease Mechanisms (2 papers), Enzyme Structure and Function (2 papers), Inflammatory Myopathies and Dermatomyositis (2 papers), Photosynthetic Processes and Mechanisms (2 papers), Porphyrin Metabolism and Disorders (2 papers), Sarcoidosis and Beryllium Toxicity Research (2 papers) and Enzyme Catalysis and Immobilization (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (296 citations), Physiology (180 citations), Rheumatology (54 citations), Immunology (60 citations) and Biochemistry (20 citations). Mark J. Hamblin has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include David J. Kelly, Maureen R. Horton, Jonathan G. Shaw, Marlies Wijsenbeek, Michael Kreuter, Keith C. Meyer, Lawrence Ho, Danielle Antin‐Ozerkis, Jeffrey A. Golden and Luca Richeldi. Their work appears in journals such as Molecular Microbiology, Neurology, The Lancet Respiratory Medicine, Pulmonary Medicine and Journal of Inflammation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.